ProQR Therapeutics PRQR
NASDAQ PRQR
$1.66 +0.01 (+0.61%)
At close: Sep 30, 2026 · 4:00 PM EDT

ProQR Therapeutics (PRQR) Convertible Debt (2013 - 2021)

Updated

ProQR Therapeutics (PRQR) reported Convertible Debt of $17,170 for the quarter ended Mar 31, 2021, down 100.0% from the prior quarter.

Analysis

ProQR Therapeutics (PRQR) Convertible Debt (2013 - 2021) Analysis & Trends

As of Dec 31, 2020, ProQR Therapeutics posted Convertible Debt of $15.77 trillion.

  • Convertible Debt has a three-year compound annual growth rate of 276203.2% (years ended Dec 2017 to Dec 2020).
  • By year, Convertible Debt came in at $2,770 in the year ended Dec 31, 2019 (+31.5%), $2,106 in the year ended Dec 31, 2018 (+181.7%) and $747.62 in the year ended Dec 31, 2017.
  • The figure for the quarter ended Mar 31, 2021 ranks as the lowest quarterly Convertible Debt since the quarter ended Dec 31, 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 ProQR Therapeutics 174.90 Mn -288.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 17,169.56
Dec 31, 2020 16,467.91 Bn
Dec 31, 2019 2,737.33
Mar 31, 2019 2.85
Dec 31, 2018 2,035.11
Sep 30, 2018 1.33
Dec 31, 2017 779.46
Dec 31, 2013 3.42 Mn
API Access

ProQR Therapeutics Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=PRQR&period=max&api_key=YOUR_API_KEY